🔴 Decoy Therapeutics is trading 4.4% down in pre-market with no confirmed catalyst

Decoy Therapeutics is trading 4.4% down at $2.59, with no confirmed company announcement explaining the pre-market decline.

• It closed at $2.71 on September 14, 2026.
• A special shareholder meeting on September 14 addressed warrant issuance and authorized-share changes, but reported results remained pending and cannot be treated as a confirmed catalyst.
• The decline does not align with an earlier reported pre-market gain, suggesting heightened volatility or an unexplained overnight trade rather than a verified fundamental event.